IRIS: imatinib mesylate superior in first-line treatment of CML
KeywordsImatinib Chronic Myeloid Leukaemia Cytarabine Mesylate Imatinib Mesylate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2002